Increased expression of collagenase-3 (MMP-13) and MT1-MMP in oesophageal cancer is related to cancer aggressiveness.
about
Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma.Ensnaring membrane type 1-matrix metalloproteinase (MT1-MMP) with tissue inhibitor of metalloproteinase (TIMP)-2 using the haemopexin domain of the protease as a carrier: a targeted approach in cancer inhibition.Alterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in esophageal carcinogenesis.Matrix metalloproteinases and gastrointestinal cancers: Impacts of dietary antioxidants.MMP-1 is a (pre-)invasive factor in Barrett-associated esophageal adenocarcinomas and is associated with positive lymph node status.Clinical significance of matrix metalloproteinase-9 expression in esophageal squamous cell carcinoma.Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.Association of matrix metalloproteinase-7 (-181A>G) polymorphism with risk of esophageal squamous cell carcinoma in Kashmir Valley.Selective Distal Enhancer Control of the Mmp13 Gene Identified through Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) Genomic Deletions.Clusterin facilitates metastasis by EIF3I/Akt/MMP13 signaling in hepatocellular carcinoma.Matrix metalloproteinase 13 activity is associated with poor prognosis in colorectal cancer.MMP-13 In-Vivo Molecular Imaging Reveals Early Expression in Lung AdenocarcinomaMMP-13 and p53 in the progression of malignant peripheral nerve sheath tumors.Membrane type 1-matrix metalloproteinase induces epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: Observations from clinical and in vitro analyses.Upregulation and differential expression of matrilysin (MMP-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett's oesophageal adenocarcinomaThe Sp1-mediaded allelic regulation of MMP13 expression by an ESCC susceptibility SNP rs2252070.MT3-MMP down-regulation promotes tumorigenesis and correlates to poor prognosis in esophageal squamous cell carcinoma.ING2 is upregulated in colon cancer and increases invasion by enhanced MMP13 expression.Selective MMP13 inhibitors.Development and Validation of a Serum Biomarker Panel for the Detection of Esophageal Squamous Cell Carcinoma through RNA Transcriptome Sequencing.Regulation of MMP13 by antitumor microRNA-375 markedly inhibits cancer cell migration and invasion in esophageal squamous cell carcinoma.Dissection of Wnt5a-Ror2 signaling leading to matrix metalloproteinase (MMP-13) expression.Expression analysis of matrix metalloproteinase-13 in human gastric cancer in the presence of Helicobacter Pylori infection.Clinical relevance of matrix metalloproteinase-13 determined with a new highly specific and sensitive ELISA in ascitic fluid of advanced ovarian carcinoma patients.Increased immunoreactivity of membrane type-1 matrix metalloproteinase (MT1-MMP) and β-catenin in high-risk basal cell carcinoma.Expression of collagenase-3 (MMP-13) enhances invasion of human fibrosarcoma HT-1080 cells.Targeted inhibition of human collagenase-3 (MMP-13) expression inhibits squamous cell carcinoma growth in vivo.Differentiated expression of membrane type metalloproteinases (MMP-14, MMP-15) and pro-MMP2 in laryngeal squamous cell carcinoma. A novel mechanism.Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression.Cyclophilin C-associated protein is a mediator for fibronectin fragment-induced matrix metalloproteinase-13 expression.Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma.Overexpression of MMP13 is associated with clinical outcomes and poor prognosis in oral squamous cell carcinoma
P2860
Q33233386-3D0F91CA-5277-475B-8A95-ABBEC61619C1Q33618445-72700304-C949-4E52-ADD4-59666A21A4B1Q33787986-8A21CC4D-E9A5-42B7-A8E5-0D7156A01DF2Q34161592-9462CBFA-6332-46C8-A1BD-FE04D87C64C3Q34258256-83C6C80F-42B1-4571-B69D-5A1E38BBC4FFQ34604748-AB65AE0E-D9F4-4943-BF3C-874726C09CB6Q34616803-BAFDDAD4-FDD5-403B-93DE-EE034CC9DFE9Q35228814-065513F4-19C0-46A0-BCF8-93C471ADE576Q35536330-0555C6AB-0B79-4EAD-B7B9-8BA3898B3691Q35550129-17CC08BB-8664-4640-9073-FC7A77871457Q35586378-79092C8B-3FB6-4A62-9369-F1E3FD262787Q35700560-6C3A5071-D13F-4FB5-94F1-5483CC2273C3Q35945077-E3886AA4-CE1C-4F4E-9FB2-0AA48387AB0BQ36621342-5D03037B-751A-4CFB-B3BF-4FA6A8BDBAD9Q36623544-6B473263-B8DC-4FCA-B75A-1B3F769A33FDQ36953774-20734614-7222-477E-B32D-0C32B2D4921DQ37321158-8D890701-122B-413B-9237-E6E3415A3DEAQ37464728-EBDB90A8-AE48-47DE-80C7-4C39BED9B8BBQ37701372-126E48E0-41F6-479A-B2A2-6D122311F39BQ38619003-CC4A51EC-D658-4EF7-9357-5DF9E9E613B4Q38737328-4A4F3079-3D33-4489-95B3-963BB9E0DFF3Q39435505-F6FAD8A5-BE01-48BC-BC23-1DA462C09091Q40356079-14A9BF8F-9210-4094-A049-9CA507075023Q40634589-1186CA22-34B7-4B45-ABF2-2219BB4E54FFQ42491031-C6CE0DE6-66C5-4101-9C10-8780906964EAQ43844097-8747888A-1307-4997-8071-F8B6176B40E6Q45234886-FE697CAA-7219-4733-98EF-C261F745AC7AQ46037583-3789B452-6362-4795-A120-2CE39374D154Q51155840-FE4E9A92-F07B-4D2E-BA52-1E28BBFE5D91Q51593419-64A1696E-53F7-4E98-B967-5EDCDAB0FE59Q54649706-9B0AC409-B200-4FB6-A32E-34AD2B9F8D33Q59101042-C7F67F4B-9B65-473C-896D-06963D1BDA68
P2860
Increased expression of collagenase-3 (MMP-13) and MT1-MMP in oesophageal cancer is related to cancer aggressiveness.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Increased expression of collag ...... ated to cancer aggressiveness.
@ast
Increased expression of collag ...... ated to cancer aggressiveness.
@en
type
label
Increased expression of collag ...... ated to cancer aggressiveness.
@ast
Increased expression of collag ...... ated to cancer aggressiveness.
@en
prefLabel
Increased expression of collag ...... ated to cancer aggressiveness.
@ast
Increased expression of collag ...... ated to cancer aggressiveness.
@en
P2093
P2860
P356
P1433
P1476
Increased expression of collag ...... ated to cancer aggressiveness.
@en
P2093
P2860
P356
10.1136/GUT.47.1.50
P407
P577
2000-07-01T00:00:00Z